Combination medication helps patients with type 2 diabetes maintain blood sugar goals
Randomized, clinical trial found that patients taking IDegLira achieved and maintained blood glucose goals longer than those taking insulin only ...
Randomized, clinical trial found that patients taking IDegLira achieved and maintained blood glucose goals longer than those taking insulin only ...
Continuous glucose monitoring demonstrates improved time-in-range, key metabolic data compared to hybrid closed-loop systemsCredit: Diabetes Research Institute/University of Miami Miller ...
CRF meeting covering the latest in structural heart disease will take place June 12-15 in Chicago WHAT: The Cardiovascular Research ...
Tim Reynolds, co-founder of Wall Street's Jane Street Capital, funds new avenue of research at the Center for Spinal Stimulation ...
Results from world first trial could influence treatment decisions for patients with oropharyngeal cancerCredit: Lawson Health Research Institute LONDON, ON ...
Combining an immunotherapy drug with two target therapies helps extend the lives of people with advanced melanoma Los Angeles - ...
Researchers received six grants totaling nearly $2.0 million to investigate novel ways to improve quality of life for individuals with ...
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer ...
1. Anonymous essay says sometimes 'choice' is a lie Impassioned author explains how extreme politics can warp patient care Abstract: ...
Researchers seek to break down HIV exclusions in cancer clinical trialsCredit: Robert Hood / Fred Hutch SEATTLE -- June 2, ...
The majority of women who underwent lumpectomy or mastectomy surgeries for breast cancer report that the scars from those surgeries ...
The Henry Ford Cancer Institute has earned a full three-year accreditation designation by the National Accreditation Program for Breast Centers ...
A pre-specified secondary analysis published today in the New England Journal of Medicine adds new information to the original TAILORx ...
Promising results that led to new $2.7 million NCI grant presented at ASCO annual meeting on June 2 CLEVELAND - ...
UCLA-led study evaluated use of drug combined with endocrine therapy in premenopausal womenCredit: UCLA Jonsson Comprehensive Cancer Center A UCLA-led ...
SALT LAKE CITY, UTAH - Today the New England Journal of Medicine published the first results of a phase III ...
The results of the ECOG-ACRIN Cancer Research Group's phase three trial, E2810, are being orally presented at the 2019 annual ...
Findings from Arm H show that in a heavily pre-treated cohort of 17 distinct tumor types -- several rare -- ...
Olaparib doubled progression-free survival for patients with BRCA mutationsCredit: Robert Kozloff, UChicago Treatment with the drug olaparib significantly reduced the ...
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.